Ken Griffin
RDHL

Ken Griffin’s Redhill Biopharma RDHL Stock Holding History

Ken Griffin’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.4K Buy
20,673
+5,196
+34% +$5.48K ﹤0.01% 12712
2025
Q4 		$15.9K Buy
+15,477
New +$20.8K ﹤0.01% 12391
2025
Q2 		– Sell
-21,512
Closed -$57.2K – 14632
2025
Q1 		$57.2K Buy
+21,512
New +$100K ﹤0.01% 12163
2024
Q3 		– Sell
-4,343
Closed -$40.2K – 15058
2024
Q2 		$40.2K Buy
+4,343
New +$48.2K ﹤0.01% 11988
2023
Q4 		– Sell
-2,231
Closed -$28.4K – 15075
2023
Q3 		$28.4K Buy
2,231
+1,602
+255% +$41.9K ﹤0.01% 12318
2023
Q2 		$19K Buy
+629
New +$36.3K ﹤0.01% 12768
2022
Q2 		– Sell
-58
Closed -$79.6K – 13886
2022
Q1 		$145K Sell
58
-45
-44% -$107K ﹤0.01% 11886
2021
Q4 		$265K Buy
103
+63
+158% +$252K ﹤0.01% 11203
2021
Q3 		$183K Buy
+40
New +$271K ﹤0.01% 12106
2020
Q4 		– Sell
-23
Closed -$207K – 11420
2020
Q3 		$240K Buy
+23
New +$189K ﹤0.01% 8519
2020
Q2 		– Sell
-19
Closed -$131K – 10378
2020
Q1 		$86K Buy
19
+7
+58% +$35K ﹤0.01% 8729
2019
Q4 		$75K Buy
+12
New +$76.7K ﹤0.01% 8654
2019
Q1 		– Sell
-18
Closed -$101K – 9760
2018
Q4 		$101K Buy
+18
New +$138K ﹤0.01% 8230
2018
Q2 		– Sell
-28
Closed -$145K – 9203
2018
Q1 		$145K Sell
28
-5
-15% -$28.8K ﹤0.01% 7560
2017
Q4 		$170K Buy
+33
New +$222K ﹤0.01% 7214

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Ken Griffin's RDHL Position: Q1 2026 in Review

Ken Griffin increased its Redhill Biopharma (RDHL) stake by 34% in Q1 2026, buying an estimated $5.48K and bringing the position to 20,673 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12712.

Ken Griffin first reported a position in RDHL in Q4 2017 and has held it in 15 quarters since. The position peaked at $265K in Q4 2021. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2026.

  • Ken Griffin held 20,673 shares of Redhill Biopharma worth $15.4K as of Q1 2026.
  • Ken Griffin bought 5,196 Redhill Biopharma shares in Q1 2026, an estimated $5.48K.
  • Redhill Biopharma made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #12712 holding.
  • Ken Griffin first reported a position in Redhill Biopharma in Q4 2017 and has held it in 15 quarters since.
  • Ken Griffin's Redhill Biopharma position peaked at $265K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.